Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020.
Wu Q, Qian M, Welby S, Guignard A, Rosillon D, Gopala K, Xu Y, Liu K, He Y, Jiang N, Tan Q, Xie J, Zhu T, Wang Q, Pan Y, Zeng R, Yang J, Zhao X, Zhou M, Navarro-Torné A, Yu H, Borys D. Wu Q, et al. Among authors: rosillon d. Hum Vaccin Immunother. 2023 Dec 15;19(3):2283912. doi: 10.1080/21645515.2023.2283912. Epub 2023 Dec 1. Hum Vaccin Immunother. 2023. PMID: 38038626 Free PMC article.
MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China.
Deng S, Welby S, Liu Z, Yang Y, Meng R, Sun Y, Yang J, Liu G, He Y, Jiang N, Wu Z, Liu K, Rosillon D, Cohet C, Borys D, Zhan S. Deng S, et al. Among authors: rosillon d. Hum Vaccin Immunother. 2023 Aug;19(2):2257989. doi: 10.1080/21645515.2023.2257989. Epub 2023 Oct 9. Hum Vaccin Immunother. 2023. PMID: 37813849 Free PMC article.
Effectiveness of maternal immunisation with a three-component acellular pertussis vaccine at preventing pertussis in infants in the United States: Post-hoc analysis of a case-control study using Bayesian dynamic borrowing.
Cheuvart B, Callegaro A, Rosillon D, Meyer N, Guignard A. Cheuvart B, et al. Among authors: rosillon d. Vaccine. 2023 Sep 15;41(40):5805-5812. doi: 10.1016/j.vaccine.2023.07.057. Epub 2023 Aug 25. Vaccine. 2023. PMID: 37635001 Free article.
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies.
Florea A, Sy LS, Ackerson BK, Qian L, Luo Y, Becerra-Culqui T, Lee GS, Tian Y, Zheng C, Bathala R, Tartof SY, Campora L, Ceregido MA, Kuznetsova A, Poirrier JE, Rosillon D, Valdes L, Cheuvart B, Mesaros N, Meyer N, Guignard A, Tseng HF. Florea A, et al. Among authors: rosillon d. Infect Dis Ther. 2023 Feb;12(2):411-423. doi: 10.1007/s40121-022-00731-8. Epub 2022 Dec 15. Infect Dis Ther. 2023. PMID: 36520325 Free PMC article.
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.
Tseng HF, Sy LS, Ackerson BK, Lee GS, Luo Y, Florea A, Becerra-Culqui T, Tartof SY, Tian Y, Taylor C, Campora L, Ceregido MA, Kuznetsova A, Poirrier JE, Rosillon D, Valdes L, Cheuvart B, Mesaros N, Meyer N, Guignard A, Qian L. Tseng HF, et al. Among authors: rosillon d. Vaccine. 2022 Jul 30;40(32):4503-4512. doi: 10.1016/j.vaccine.2022.06.009. Epub 2022 Jun 16. Vaccine. 2022. PMID: 35717267 Free article.
Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up.
Praet N, Asante KP, Bozonnat MC, Akité EJ, Ansah PO, Baril L, Boahen O, Mendoza YG, Haine V, Kariuki S, Lamy M, Maleta K, Mungwira R, Ndeketa L, Oduro A, Ogutu B, Olewe F, Oneko M, Orsini M, Roman F, Bahmanyar ER, Rosillon D, Schuerman L, Sing'oei V, Terlouw DJ, Wéry S, Otieno W, Pirçon JY. Praet N, et al. Among authors: rosillon d. Malar J. 2022 Apr 25;21(1):132. doi: 10.1186/s12936-022-04144-3. Malar J. 2022. PMID: 35468801 Free PMC article.
Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016.
Welby S, Rosillon D, Feng Y, Borys D. Welby S, et al. Among authors: rosillon d. Expert Rev Vaccines. 2022 Mar;21(3):407-413. doi: 10.1080/14760584.2022.2021077. Epub 2022 Jan 24. Expert Rev Vaccines. 2022. PMID: 34939897 Clinical Trial.
58 results